Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue

被引:72
作者
Fang, ZJ
Yang, SJ
Gurates, B
Tamura, M
Simpson, E
Evans, D
Bulun, SE
机构
[1] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Mol Genet, Chicago, IL 60612 USA
[3] Monash Univ, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[4] Novartis Pharmaceut, CH-4002 Basel, Switzerland
关键词
D O I
10.1210/jc.87.7.3460
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aromatase P450 (P450arom) is the key enzyme for the biosynthesis of estrogen that is essential for the growth of human endometriosis, a pathology characterized by endometrium-like tissue on the peritoneal surfaces of abdominal organs manifest by pelvic pain and infertility. Surgically transplanted autologous uterine tissue to ectopic sites on the peritoneum in mice has been used as an animal model to study endometriosis. Using this mouse model, we evaluated the roles of the P450arom gene and aromatase enzyme activity in the growth of endometriosis represented by ectopic uterine tissues in mice. Endometriosis was induced surgically in the following groups of mice: 1) untreated transgenic mice with disrupted P450arom gene (ArKO); 2) ArKO mice treated with systemic estrogen; 3) untreated wild-type (WT) mice; 4) WT mice treated with estrogen; 5) WT mice treated with the aromatase inhibitor, letrozole; and 6) WT mice treated with letrozole and estrogen. Each group contained eight mice; +/+ littermates of ArKO mice were used as WT controls. Treatment with estrogen increased the size of ectopic uterine tissues in ArKO and WT mice significantly. The ectopic uterine lesions in untreated and estrogen -treated ArKO mice were strikingly smaller than those in untreated and estrogen -treated WT controls, respectively. Systemic treatment of WT mice with letrozole significantly decreased the lesion size in a dose-dependent manner. The addition of estrogen to letrozole treatment increased the ectopic lesion size, although these lesions were significantly smaller than those in mice treated with estrogen only. As tissue controls, the effects of these conditions on normally located (eutopic) uterine tissue were evaluated. The effects of disruption of the P450arom gene and treatments with Ietrozole and estrogen seemed to be more profound on ectopic tissues, suggesting that ectopic tissues might be more sensitive to estrogen for growth. We conclude that both an intact P450arom gene and the presence of aromatase enzyme activity are essential for the growth of ectopic uterine tissue in a mouse model of endometriosis.
引用
收藏
页码:3460 / 3466
页数:7
相关论文
共 21 条
[1]  
BARRAGAN JC, 1992, FERTIL STERIL, V58, P1215
[2]   An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene [J].
Britt, KL ;
Drummond, AE ;
Cox, VA ;
Dyson, M ;
Wreford, NG ;
Jones, MEE ;
Simpson, ER ;
Findlay, JK .
ENDOCRINOLOGY, 2000, 141 (07) :2614-2623
[3]   Aromatase in aging women [J].
Bulun, SE ;
Zeitoun, K ;
Sasano, H ;
Simpson, ER .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1999, 17 (04) :349-358
[4]  
CUMMINGS AM, 1995, REPROD TOXICOL, V9, P223
[5]  
DIZEREGA GS, 1980, FERTIL STERIL, V33, P649
[6]   Epidemiology of endometriosis [J].
Eskenazi, B ;
Warner, ML .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (02) :235-+
[7]   Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene [J].
Fisher, CR ;
Graves, KH ;
Parlow, AF ;
Simpson, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6965-6970
[8]  
Harada N, 1989, Nihon Rinsho, V47, P2287
[9]   HORMONAL-REGULATION, TISSUE DISTRIBUTION, AND CONTENT OF AROMATASE CYTOCHROME-P450 MESSENGER RIBONUCLEIC-ACID AND ENZYME IN RAT OVARIAN FOLLICLES AND CORPORA-LUTEA - RELATIONSHIP TO ESTRADIOL BIOSYNTHESIS [J].
HICKEY, GJ ;
CHEN, S ;
BESMAN, MJ ;
SHIVELY, JE ;
HALL, PF ;
GADDYKURTEN, D ;
RICHARDS, JS .
ENDOCRINOLOGY, 1988, 122 (04) :1426-1436
[10]   Prostaglandin E(2) stimulates aromatase expression in endometriosis-derived stromal cells [J].
Noble, LS ;
Takayama, K ;
Zeitoun, KM ;
Putman, JM ;
Johns, DA ;
Hinshelwood, MM ;
Agarwal, VR ;
Zhao, Y ;
Carr, BR ;
Bulun, SE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :600-606